“Studies show” is one of the least informative phrases in health writing. What kind of study? In which species? Compared with what? Measuring which outcome? Those details determine how much a result can tell us.
Evidence is a ladder, not a switch. Cell and animal studies can generate hypotheses; well-designed human trials are needed to establish benefits and harms for people.
Laboratory or cell evidence
In-vitro studies examine cells, proteins, tissues, or chemical systems under controlled conditions. They can reveal mechanisms and identify promising directions. But concentrations used in a dish may not be achievable or safe in the body, and isolated cells do not reproduce metabolism, immune responses, behaviour, or long-term effects.
Animal evidence
Animal models help researchers study whole-body processes and potential toxicity before some human trials. A mouse tendon model or rat stomach-injury model is not the same as a Canadian patient with a sports injury or chronic illness. Differences in species, disease model, route, and outcome can prevent findings from translating.
Observational human evidence
Observational studies measure what happens without randomly assigning the intervention. They can reveal patterns and rare harms, but other differences between groups may explain the association. People choosing a treatment may differ in health, income, behaviour, access to care, or other ways.
Randomized controlled trials
Random assignment can reduce confounding, and blinding can reduce expectation and measurement bias. Still, trial quality depends on sample size, comparator, outcome selection, missing data, follow-up, protocol changes, and whether the measured outcome matters to patients.
A small Phase 1 study is usually designed mainly to learn about safety, tolerability, or pharmacokinetics – not to prove that a treatment works. A registered trial with no posted results should not be counted as positive evidence.
Systematic reviews and guidelines
A careful systematic review uses a defined method to find and evaluate all relevant studies. Its conclusion can still be weak if the included evidence is small, biased, inconsistent, or not applicable. Guidelines add clinical context, values, feasibility, and harms – but their methods and conflicts should be inspected too.
Surrogate outcomes versus outcomes people feel
A biomarker, receptor signal, imaging measure, or laboratory value can be useful without proving that people live longer, heal faster, function better, or feel better. Ask whether the study measured a validated surrogate or a patient-important outcome.
A six-question study check
- Was this conducted in cells, animals, or people?
- Was there a suitable control group and random assignment?
- How many participants were studied, and for how long?
- Was the outcome chosen before the results were known?
- Do the reported differences matter clinically, not just statistically?
- Who funded the work, and are the results replicated independently?
Apply the right conclusion
A sound sentence is often narrower than the headline: “This compound changed a marker in a mouse model” rather than “this peptide repairs tissue.” Narrow conclusions are not pessimism. They are how science stays honest while better evidence is built.
Source trail